Blue Capital Inc’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Blue Capital Inc's LLY Position: Q2 2026 in Review
Blue Capital Inc reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $522K and leaving 3,107 shares worth $3.73M. The position accounts for 2.37% of the portfolio, ranked #5.
Blue Capital Inc first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.77M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Blue Capital Inc held 3,107 shares of Eli Lilly worth $3.73M as of Q2 2026.
- Blue Capital Inc sold 511 Eli Lilly shares in Q2 2026, an estimated $522K.
- Eli Lilly made up 2.37% of Blue Capital Inc's portfolio in Q2 2026, its #5 holding.
- Blue Capital Inc first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Blue Capital Inc's Eli Lilly position peaked at $3.77M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Blue Capital Inc's 13F filing for Q2 2026, filed 11 Aug 2026.